Long-term changes in reward-seeking following morphine withdrawal are associated with altered N-methyl-d-aspartate receptor 1 splice variants in the amygdala

Neuroscience

Volumn 223, Issue , 2012, Pages 45-55

  Anderson, E M ^b   Neubert, J K ^c   Caudle, R M ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

Amygdala; NMDA receptor; Operant; Opiate; Splicing; Withdrawal

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; PROTEIN VARIANT;

ALTERNATIVE RNA SPLICING; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; ASSAY; AVERSION; CONTROLLED STUDY; DISEASE COURSE; DRUG SEEKING BEHAVIOR; DRUG WITHDRAWAL; HYPERSENSITIVITY; MALE; MENTAL STRESS; MORPHINE ADDICTION; MOTIVATION; NONHUMAN; OPERANT OROFACIAL ASSAY; PAIN; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TEMPERATURE;

ALTERNATIVE SPLICING; AMYGDALA; ANALYSIS OF VARIANCE; ANIMALS; CONDITIONING, OPERANT; DENSITOMETRY; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; MALE; MORPHINE; NARCOTICS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; REWARD; SUBSTANCE WITHDRAWAL SYNDROME; TEMPERATURE; TIME FACTORS;

EID: 84865458118     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.07.037     Document Type: Article

References (55)

1. Anderson E.M., Valle-Pinero A.Y., Suckow S.K., Nolan T.A., Neubert J.K., Caudle R.M. Morphine and MK-801 administration leads to alternative N-methyl-d-aspartate receptor 1 splicing and associated changes in reward seeking behavior and nociception on an operant orofacial assay. Neuroscience 2012, 214:14-27.
2. Angst M.S., Clark J.D. Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology 2006, 104:570-587.
3. Ansah O.B., Bourbia N., Goncalves L., Almeida A., Pertovaara A. Influence of amygdaloid glutamatergic receptors on sensory and emotional pain-related behavior in the neuropathic rat. Behav Brain Res 2010, 209:174-178.
4. Avila M.A., Ruggiero R.N., Cabral A., Brandao M.L., Nobre M.J., Castilho V.M. Involvement of the midbrain tectum in the unconditioned fear promoted by morphine withdrawal. Eur J Pharmacol 2008, 590:217-223.
5. Bie B., Peng Y., Zhang Y., Pan Z.Z. CAMP-mediated mechanisms for pain sensitization during opioid withdrawal. J Neurosci 2005, 25:3824-3832.
6. Bradley J., Carter S.R., Rao V.R., Wang J., Finkbeiner S. Splice variants of the NR1 subunit differentially induce NMDA receptor-dependent gene expression. J Neurosci 2006, 26:1065-1076.
7. Cabral A., Ruggiero R.N., Nobre M.J., Brandao M.L., Castilho V.M. GABA and opioid mechanisms of the central amygdala underlie the withdrawal-potentiated startle from acute morphine. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:334-344.
8. Castilho V.M., Borelli K.G., Brandao M.L., Nobre M.J. Anxiety-like symptoms induced by morphine withdrawal may be due to the sensitization of the dorsal periaqueductal grey. Physiol Behav 2008, 94:552-562.
9. Crombag H.S., Bossert J.M., Koya E., Shaham Y. Review. Context-induced relapse to drug seeking: a review. Philos Trans R Soc Lond B Biol Sci 2008, 363:3233-3243.
10. Cull-Candy SG, Leszkiewicz DN (2004) Role of distinct NMDA receptor subtypes at central synapses. Sci STKE 2004: re16.
11. Dingledine R., Borges K., Bowie D., Traynelis S.F. The glutamate receptor ion channels. Pharmacol Rev 1999, 51:7-61.
12. Doyle T.G., Berridge K.C., Gosnell B.A. Morphine enhances hedonic taste palatability in rats. Pharmacol Biochem Behav 1993, 46:745-749.
13. Duka T., Crombag H.S., Stephens D.N. Experimental medicine in drug addiction: towards behavioral, cognitive and neurobiological biomarkers. J Psychopharmacol 2011, 25:1235-1255.
14. Gardner E.L. Addiction and brain reward and antireward pathways. Adv Psychosom Med 2011, 30:22-60.
15. Gaunitz C., Schuttler A., Gillen C., Allgaier C. Formalin-induced changes of NMDA receptor subunit expression in the spinal cord of the rat. Amino Acids 2002, 23:177-182.
16. Glass M.J. The role of functional postsynaptic NMDA receptors in the central nucleus of the amygdala in opioid dependence. Vitam Horm 2010, 82:145-166.
17. Glass M.J., Hegarty D.M., Oselkin M., Quimson L., South S.M., Xu Q., Pickel V.M., Inturrisi C.E. Conditional deletion of the NMDA-NR1 receptor subunit gene in the central nucleus of the amygdala inhibits naloxone-induced conditioned place aversion in morphine-dependent mice. Exp Neurol 2008, 213:57-70.
18. Glass M.J., Vanyo L., Quimson L., Pickel V.M. Ultrastructural relationship between N-methyl-d-aspartate-NR1 receptor subunit and mu-opioid receptor in the mouse central nucleus of the amygdala. Neuroscience 2009, 163:857-867.
19. Goode P.G. An implanted reservoir of morphine solution for rapid induction of physical dependence in rats. Br J Pharmacol 1971, 41:558-566.
20. Hayes R.J., Gardner E.L. The basolateral complex of the amygdala mediates the modulation of intracranial self-stimulation threshold by drug-associated cues. Eur J Neurosci 2004, 20:273-280.
21. Heinz A., Beck A., Grusser S.M., Grace A.A., Wrase J. Identifying the neural circuitry of alcohol craving and relapse vulnerability. Addict Biol 2009, 14:108-118.
22. Hou Y.Y., Lu B., Li M., Liu Y., Chen J., Chi Z.Q., Liu J.G. Involvement of actin rearrangements within the amygdala and the dorsal hippocampus in aversive memories of drug withdrawal in acute morphine-dependent rats. J Neurosci 2009, 29:12244-12254.
23. Katsuura Y., Heckmann J.A., Taha S.A. Mu-Opioid receptor stimulation in the nucleus accumbens elevates fatty tastant intake by increasing palatability and suppressing satiety signals. Am J Physiol Regul Integr Comp Physiol 2011, 301:R244-R254.
24. Koob G.F. Neurobiological substrates for the dark side of compulsivity in addiction. Neuropharmacology 2009, 56(Suppl. 1):18-31.
25. Koob G.F., Le Moal M. Plasticity of reward neurocircuitry and the 'dark side' of drug addiction. Nat Neurosci 2005, 8:1442-1444.
26. Loftis J.M., Janowsky A. Cocaine treatment- and withdrawal-induced alterations in the expression and serine phosphorylation of the NR1 NMDA receptor subunit. Psychopharmacology (Berl) 2002, 164:349-359.
27. Manning B.H., Mayer D.J. The central nucleus of the amygdala contributes to the production of morphine antinociception in the formalin test. Pain 1995, 63:141-152.
28. Manning B.H., Mayer D.J. The central nucleus of the amygdala contributes to the production of morphine antinociception in the rat tail-flick test. J Neurosci 1995, 15:8199-8213.
29. Marlatt G.A. Cue exposure and relapse prevention in the treatment of addictive behaviors. Addict Behav 1990, 15:395-399.
30. Neubert J.K., Rossi H.L., Malphurs W., Vierck C.J., Caudle R.M. Differentiation between capsaicin-induced allodynia and hyperalgesia using a thermal operant assay. Behav Brain Res 2006, 170:308-315.
31. Neubert J.K., Widmer C.G., Malphurs W., Rossi H.L., Vierck C.J., Caudle R.M. Use of a novel thermal operant behavioral assay for characterization of orofacial pain sensitivity. Pain 2005, 116:386-395.
32. Nikonenko I., Jourdain P., Alberi S., Toni N., Muller D. Activity-induced changes of spine morphology. Hippocampus 2002, 12:585-591.
33. Nocjar C., Panksepp J. Prior morphine experience induces long-term increases in social interest and in appetitive behavior for natural reward. Behav Brain Res 2007, 181:191-199.
34. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1998, Academic Press, San Diego, CA.
35. Prybylowski K.L., Grossman S.D., Wrathall J.R., Wolfe B.B. Expression of splice variants of the NR1 subunit of the N-methyl-d-aspartate receptor in the normal and injured rat spinal cord. J Neurochem 2001, 76:797-805.
36. Raeder H., Holter S.M., Hartmann A.M., Spanagel R., Moller H.J., Rujescu D. Expression of N-methyl-d-aspartate (NMDA) receptor subunits and splice variants in an animal model of long-term voluntary alcohol self-administration. Drug Alcohol Depend 2008, 96:16-21.
37. Rameau G.A., Akaneya Y., Chiu L., Ziff E.B. Role of NMDA receptor functional domains in excitatory cell death. Neuropharmacology 2000, 39:2255-2266.
38. Reti I.M., Crombag H.S., Takamiya K., Sutton J.M., Guo N., Dinenna M.L., Huganir R.L., Holland P.C., Baraban J.M. Narp regulates long-term aversive effects of morphine withdrawal. Behav Neurosci 2008, 122:760-768.
39. Rezayof A., Golhasani-Keshtan F., Haeri-Rohani A., Zarrindast M.R. Morphine-induced place preference. Involvement of the central amygdala NMDA receptors. Brain Res 2007, 1133:34-41.
40. Schmidt E.D., Voorn P., Binnekade R., Schoffelmeer A.N., De Vries T.J. Differential involvement of the prelimbic cortex and striatum in conditioned heroin and sucrose seeking following long-term extinction. Eur J Neurosci 2005, 22:2347-2356.
41. Schulteis G., Yackey M., Risbrough V., Koob G.F. Anxiogenic-like effects of spontaneous and naloxone-precipitated opiate withdrawal in the elevated plus-maze. Pharmacol Biochem Behav 1998, 60:727-731.
42. Shaw-Lutchman T.Z., Barrot M., Wallace T., Gilden L., Zachariou V., Impey S., Duman R.S., Storm D., Nestler E.J. Regional and cellular mapping of cAMP response element-mediated transcription during naltrexone-precipitated morphine withdrawal. J Neurosci 2002, 22:3663-3672.
43. Spuz C.A., Borszcz G.S. NMDA or non-NMDA receptor antagonism within the amygdaloid central nucleus suppresses the affective dimension of pain in rats: evidence for hemispheric synergy. J Pain 2012, 13:328-337.
44. Stinus L., Le Moal M., Koob G.F. Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience 1990, 37:767-773.
45. Taha S.A., Katsuura Y., Noorvash D., Seroussi A., Fields H.L. Convergent, not serial, striatal and pallidal circuits regulate opioid-induced food intake. Neuroscience 2009, 161:718-733.
46. Tingley W.G., Ehlers M.D., Kameyama K., Doherty C., Ptak J.B., Riley C.T., Huganir R.L. Characterization of protein kinase A and protein kinase C phosphorylation of the N-methyl-d-aspartate receptor NR1 subunit using phosphorylation site-specific antibodies. J Biol Chem 1997, 272:5157-5166.
47. Watanabe T., Nakagawa T., Yamamoto R., Maeda A., Minami M., Satoh M. Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats. Jpn J Pharmacol 2002, 88:399-406.
48. Williams J.T., Christie M.J., Manzoni O. Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev 2001, 81:299-343.
49. Winkler A., Mahal B., Kiianmaa K., Zieglgansberger W., Spanagel R. Effects of chronic alcohol consumption on the expression of different NR1 splice variants in the brain of AA and ANA lines of rats. Brain Res Mol Brain Res 1999, 72:166-175.
50. Zhang M., Kelley A.E. Intake of saccharin, salt, and ethanol solutions is increased by infusion of a mu opioid agonist into the nucleus accumbens. Psychopharmacology (Berl) 2002, 159:415-423.
51. Zhou F.C., Anthony B., Dunn K.W., Lindquist W.B., Xu Z.C., Deng P. Chronic alcohol drinking alters neuronal dendritic spines in the brain reward center nucleus accumbens. Brain Res 2007, 1134:148-161.
52. Zhou Q., Caudle R.M., Price D.D., Valle-Pinero A.Y., Verne G.N. Selective up-regulation of NMDA-NR1 receptor expression in myenteric plexus after TNBS induced colitis in rats. Mol Pain 2006, 2:3.
53. Zhou Q., Price D.D., Caudle R.M., Verne G.N. Spinal NMDA NR1 subunit expression following transient TNBS colitis. Brain Res 2009, 1279:109-120.
54. Zhu W., Pan Z.Z. Synaptic properties and postsynaptic opioid effects in rat central amygdala neurons. Neuroscience 2004, 127:871-879.
55. Zhu W., Pan Z.Z. Mu-opioid-mediated inhibition of glutamate synaptic transmission in rat central amygdala neurons. Neuroscience 2005, 133:97-103.